DIMENSIONAL FUND ADVISORS LP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,024,553
-36.9%
860,135
-12.0%
0.01%
-37.5%
Q2 2023$25,405,034
-9.6%
977,862
-0.0%
0.01%
-11.1%
Q1 2023$28,096,203
+98795.5%
978,300
+1.9%
0.01%
+12.5%
Q4 2022$28,410
-99.9%
959,746
+2.1%
0.01%
-11.1%
Q3 2022$22,367,000
+11.2%
939,802
+4.3%
0.01%
+28.6%
Q2 2022$20,108,000
-8.0%
900,887
+3.5%
0.01%0.0%
Q1 2022$21,853,000
-28.8%
870,299
+1.7%
0.01%
-22.2%
Q4 2021$30,675,000
-16.4%
856,124
-0.7%
0.01%
-25.0%
Q3 2021$36,683,000
-0.7%
861,933
+1.0%
0.01%0.0%
Q2 2021$36,958,000
+5.0%
853,720
-0.8%
0.01%0.0%
Q1 2021$35,186,000
-12.1%
860,554
-2.7%
0.01%
-14.3%
Q4 2020$40,015,000
+22.7%
884,116
-4.1%
0.01%0.0%
Q3 2020$32,613,000
-7.2%
921,580
-1.0%
0.01%
-6.7%
Q2 2020$35,137,000
+29.0%
931,332
-1.2%
0.02%
+7.1%
Q1 2020$27,240,000
-47.5%
942,233
-5.9%
0.01%
-26.3%
Q4 2019$51,917,000
-9.5%
1,001,294
-4.2%
0.02%
-13.6%
Q3 2019$57,359,000
+34.6%
1,044,991
-0.4%
0.02%
+29.4%
Q2 2019$42,622,000
+37.6%
1,049,305
+2.5%
0.02%
+41.7%
Q1 2019$30,971,000
-7.6%
1,024,179
+2.7%
0.01%
-20.0%
Q4 2018$33,523,000
-20.3%
997,441
-0.0%
0.02%
-6.2%
Q3 2018$42,074,000
+34.5%
997,485
+2.0%
0.02%
+33.3%
Q2 2018$31,282,000
-32.4%
977,569
+5.0%
0.01%
-36.8%
Q1 2018$46,278,000
-4.8%
930,771
+3.3%
0.02%
-5.0%
Q4 2017$48,589,000
-6.5%
901,304
+0.6%
0.02%
-13.0%
Q3 2017$51,945,000
+19.9%
895,600
+2.0%
0.02%
+15.0%
Q2 2017$43,321,000
+29.2%
878,006
+13.8%
0.02%
+25.0%
Q1 2017$33,522,000
-6.4%
771,699
+5.5%
0.02%
-11.1%
Q4 2016$35,823,000
+2.6%
731,679
+0.2%
0.02%
-5.3%
Q3 2016$34,926,000
-13.0%
729,924
-2.4%
0.02%
-17.4%
Q2 2016$40,134,000
+14.9%
748,083
-4.2%
0.02%
+9.5%
Q1 2016$34,935,000
+18.1%
781,196
+0.8%
0.02%
+16.7%
Q4 2015$29,575,000
+26.6%
775,025
+5.6%
0.02%
+20.0%
Q3 2015$23,359,000
-1.6%
733,870
+2.1%
0.02%0.0%
Q2 2015$23,750,000
-18.9%
719,061
+1.1%
0.02%
-16.7%
Q1 2015$29,281,000
-10.5%
711,225
-11.4%
0.02%
-14.3%
Q4 2014$32,717,000
-6.0%
803,068
-15.4%
0.02%
-16.0%
Q3 2014$34,789,000
-21.1%
948,932
-0.2%
0.02%
-19.4%
Q2 2014$44,066,000
+15.2%
951,130
+2.2%
0.03%
+6.9%
Q1 2014$38,242,000
+9.3%
930,486
+1.5%
0.03%
+7.4%
Q4 2013$34,980,000
+66.1%
916,678
+4.3%
0.03%
+50.0%
Q3 2013$21,057,000
+47.7%
878,814
+4.8%
0.02%
+38.5%
Q2 2013$14,258,000838,7120.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Trigran Investments, Inc. 954,799$23,975,0002.44%
CAPITAL MANAGEMENT CORP /VA 202,258$5,079,0001.09%
Riverwater Partners LLC 12,370$311,0000.51%
DIKER MANAGEMENT LLC 21,835$548,0000.44%
Ranger Investment Management 136,381$3,425,0000.22%
CHATHAM CAPITAL GROUP, INC. 23,757$597,0000.12%
Teton Advisors, Inc. 22,000$552,0000.10%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,412,259$35,462,0000.09%
Intercontinental Wealth Advisors, LLC 14,257$358,0000.08%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 385,528$9,681,0000.06%
View complete list of ANIKA THERAPEUTICS INC shareholders